4 robotics stocks Fools think could deliver explosive growth

These stocks are appealing for their growth potential, given the increasing adoption of robotics across various industries.

| More on:
Senior woman potting plant in garden at home

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors looking for growth stocks are likely constantly on the lookout for the ‘next big thing’.

Robotics stocks are considered part of the technology sector or, more specifically, within sub-sectors focused on automation and advanced manufacturing.

Below are four that a selection of our free-site contract investment writers are highlighting as worth a second look today…

Emerson Electric

What it does: Emerson Electric is a US-based multinational that makes products for a range of commercial and consumer uses.

By Christopher Ruane. Emerson Electric (NYSE: EMR) is not a new kid on the block. The storied manufacturer has been on the go since the 19th century. But it is not stuck in the past and has embraced the robotics age by producing a wide range of products aimed at industrial and factory automation. Its Ovation automation technology sits underneath 20% of global power generation.

The business has raised its full-year outlook, with the chief executive telling investors, “we are energized about the power of our differentiated automation portfolio.” One risk is ongoing weakness in factory automation after a recent strong run, especially in the Chinese market.

But Emerson is solidly profitable and offers a dividend yield of 2.0%. The shares have risen 67% in five years.

I think ongoing demand for new automation products and servicing existing ones for its large installed customer base could help power the Emerson share price further.

Christopher Ruane does not own shares in Emerson Electric.

Intuitive Surgical

What it does: Intuitive Surgical is the world leader in robotic surgery, renowned for its Da Vinci systems.

By Oliver Rodzianko. Intuitive Surgical (NASDAQ:ISRG) is one of the most exciting companies I know of right now. Its Da Vinci systems are truly breathtaking. These allow a more precise and less invasive form of surgery in which surgeons perform operations remotely.

In addition, it’s the current leader in the field. Therefore, I think the company is the best positioned to transition to autonomous robotic surgery in the future. For this reason, I can imagine Intuitive Surgical becoming one of the hottest investments in the coming years.

However, the company might not effectively make the transition. It could find itself outcompeted by new startups which are offering AI and robotics operations. That’s a long-term risk versus a potential reward that I’m considering.

I reckon I’ll be investing in Intuitive Surgical soon. Even though its valuation is very high, with a price-to-earnings ratio of around 75, the stock price just keeps on chugging higher.

Oliver Rodzianko does not own shares in Intuitive Surgical.

Smith & Nephew

What it does: Smith & Nephew supplies medical devices in the fields of orthopaedics, sports medicine and wound management.

Medical business Smith & Nephew (LSE:SN.) has been around since 1856. But it’s no stranger to evolution and more recently has been devoting vast sums to the realm of surgical robotics.

The FTSE 100 company’s robot-assisted technologies allow healthcare workers greater precision while carrying out procedures. The benefits are an improved chance of surgical success and reduced recovery times for the patient.

Smith & Nephew’s ‘CORI Surgical System’ is the only robotics technology currently available for partial and total knee reconstruction. The company sees this as a key area for growth, and has added new functions and features to CORI over the past year.

Analysts at Mordor Intelligence expect the medical robotics market to grow at an annualised rate of 16.1% during the next five years. I believe Smith & Nephew’s huge investment in this area could yield significant results.

Royston Wild does not own shares in Smith & Nephew.

Symbotic

What it does: Symbotic is an AI-powered robotics and software company whose products help automate supply chain operations in warehouses.

By Ben McPoland. When I think of the robot revolution, Intuitive Surgical springs to mind. However, I’d expect steady compounding growth for Intuitive rather than explosive. Not so Symbotic (NASDAQ: SYM),though, which is a much smaller firm at an earlier stage of its growth trajectory.

The company’s robotic systems automate picking, packing, and the stacking and unstacking of goods onto pallets. It has smart backing in the shape of Walmart and Softbank, while Target is also a customer.

In Q2, revenue surged 59% year on year to $424m, topping Wall Street’s estimates. And while the company lost $41m in the quarter, analysts expect it to turn profitable within the next two years.

One risk I’d highlight here is very high customer concentration. Symbotic has a deal to implement its robots in all 42 of Walmart’s regional distribution centres in the coming years. If the retail giant paused this rollout, the firm’s growth would suffer badly. The overall market is also very competitive. 

Still, revenue is forecast to grow above 40% in each of the next three years. That’s pretty explosive!

Ben McPoland owns shares in Intuitive Surgical.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

The Motley Fool UK has recommended Intuitive Surgical, Smith & Nephew Plc, and Walmart. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Top Stocks

Investing Articles

3 shares that Fools believe will outperform Lloyds over the next 5 years

Today, we're not discussing whether 'crowd wisdom' is correct regarding shares in Lloyds as a potential investment. We're looking further…

Read more »

Investing Articles

Best British growth stocks to consider buying in October

We asked our freelance writers to reveal the top growth stocks they’d buy in October, which included three 'Fire' recs!

Read more »

Investing Articles

Best AIM stocks to consider buying in October

We asked our writers to share their best AIM-listed stocks to buy in October, featuring a Hidden Winners recommendation!

Read more »

Investing Articles

Best British dividend stocks to consider buying in October

We asked our writers to share their top dividend stock for October, including a Share Advisor 'Ice' rec!

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Best US stocks to consider buying in October

We asked our freelance writers to reveal the top US stocks they’d buy in October, which included two Share Advisor…

Read more »

Investing Articles

5 tech stocks that look cheap after the selloff

The perception of getting "more for less" can be appealing. But that's not what we look for in a 'cheap…

Read more »

Investing Articles

4 defensive stocks Fools have bought for long-term gains

When buying stocks, many growth investors wisely choose to diversify with some solid, stable companies in their portfolio.

Read more »

Investing Articles

8 shares that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these shares in recent weeks.

Read more »